Arthrex has secured the US Food and Drug Administration (FDA) clearance for its NanoScope system, allowing its use in paediatric orthopaedic and laparoscopic procedures.
The NanoScope system is a compact, mobile imaging platform that integrates a 3-in-1, high-definition chip-on-tip single-use camera system.
It combines 1mm imaging sensors, LED lighting, image management, and operating room integration, all controlled through an intuitive tablet.
With a design that enhances its portability and usability, the system is tailored to meet the unique anatomical needs of young patients in minimally invasive surgeries.
The NanoScope system can be used for common paediatric cases such as knee arthroscopy, meniscal treatments, anterior cruciate ligament (ACL) reconstruction, shoulder arthroscopy, and abdominal hernia or diagnostic laparoscopy.
Its smaller scope design aims to reduce the risk of damaging anatomical and neurovascular structures during procedures.
The system’s portability allows many procedures to be performed outside traditional operating rooms, such as in physician offices or ambulatory surgery centres.
The flexibility offers a convenient option for diagnosis and treatment, with patients and doctors able to choose appropriate anaesthesia levels, from local to mild sedation.
The minimally invasive nature of the system results in smaller scars, reduced infection risk, and potentially less pain, decreasing the need for prescriptive pain medications.
Arthrex founder and president Reinhold Schmieding said: “This innovative and disruptive technology is transforming the way we approach diagnostic and least-invasive surgical treatments, and we are extremely proud to expand its indications to the field of paediatric orthopaedics and laparoscopy.”
Orthopaedic surgeon J Lee Pace said: “FDA clearance for use of the NanoScope system in pediatric patients is an important, exciting step forward. Its smaller size makes it ideal for navigating pediatric joints while still delivering excellent image quality for routine or even more complex cases.”
Based in Naples, Florida, Arthrex specialises in minimally invasive surgical technology, scientific research, and medical education.
The company develops over 1,000 new products and procedures annually, advancing orthopaedic surgery, trauma, spine, cardiothoracic, orthobiologics, and arthroplasty globally.
Last month, Arthrex unveiled the Synergy Power system, its new battery-powered toolset designed to support orthopaedic surgical procedures.
The system includes two main components: the dual trigger rotary drill and the sagittal saw, both designed to enhance precision and flexibility for surgical teams.
